A novel formulation approach for preparation of nanoparticulate red mold rice

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 18, 2006, Pages 6845-6851

  Yu, Chiun Chieh ^a   Lee, Chun Lin ^a   Pan, Tzu Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Citrinin; Monacolin K; Monascu; Nanoparticulate

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; CHEMISTRY; FOOD HANDLING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; MICROBIOLOGY; MONASCUS; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PLANT SEED; RICE;

ANTICHOLESTEREMIC AGENTS; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FOOD HANDLING; HYDROGEN-ION CONCENTRATION; MONASCUS; ORYZA SATIVA; PARTICLE SIZE; SEEDS;

MONASCUS;

EID: 33748908778     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0609274     Document Type: Article

References (34)

1. Su, Y. C.; Chen, W. L.; Lee, Y. H. Studies on the Anka Pigment Product by a Mutant of Monascus Anka Memorial Collect of Agriculture; National Taiwan University: Taipei, 1973; Vol. 14, pp 41-56 (in Chinese).
2. Tsuji, K.; Ichikawa, T.; Tanabe, N.; Obata, H.; Abe, S.; Tarui, S.; Nakagawa, Y. Extraction of hypotensive substance from weat beni-koji. Nippon Shokuhin Kogyo Gakkaish 1992, 39, 913-918.
3. Budavari, S.; Maryadele, J. O.; Smith, A.; Heckelman, P. E. The Merck Index; Merck & Co.: Rahway, NJ, 1989; Vol. 11, pp 2330-2331.
4. Endo, A. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-methylglutaryl coenzyme A reductase. J. Antibiot. 1980, 23, 334-337.
5. Su, Y. C.; Wang, J. J.; Lin, T. T.; Pan, T. M. Production of the secondary metabolites γ-aminobutyric acid and monacolin K by Monascus. J. Ind. Microbiol. Biotechnol. 2003, 30, 41-46.
6. Kohama, Y.; Matsumoto, S.; Mimura, T.; Tanabe, N.; Inada, A.; Nakanishi, T. Isolation and identification of hypotensive principles in red-mold rice. Chem. Pharm. Bull. 1987, 35, 2484-2489.
7. Kushiro, T.; Hashida, J.; Kawamura, H.; Mitsubayashi, H.; Saito, T.; Suzuki, Y.; Takahashi, N.; Ishii, T.; Kimura, T.; Tsuji, K.; Tanabe, N.; Asano, K.; Abe, S.; Tarui, S. Clinical effects of benikoji in mild essential hypertension - A multi-center double-blind comparison with placebo. Nippon Jinzo Gakkai Shi 1996, 38, 625-633.
8. Aniya, Y.; Yokomakura, T.; Tonamine, M.; Shimada, K.; Nagamine, T.; Shimabukura, M.; Gibo, H. Screening of antioxidant action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats. Gen. Pharmacol. 1999, 32, 225-231.
9. Blanc, P. J.; Loret, M. O.; Goma, G. Production of citrinin by various species of Monascus. Biotechnol. Lett. 1995, 17, 291-294.
10. Heber, D.; Yip, I.; Ashley, J. M.; Elashoff, D. A.; Elashoff, R. M.; Go, V. L. W. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am. J. Clin. Nutr. 1999, 69, 231-236.
11. Liversidge, G. G.; Cundy, K. C.; Bishop, J. F.; Czekai, D. A. Surface modified drug nanoparticles. U.S. Patent 5,145,684, 1992.
12. Yokoyama, T.; Huang, C. C. Nanoparticle technology for the production of functional materials. "KONA" Powder Sci. Technol. Jpn. 2005, 23, 7-16.
13. Merisko-Liversidge, E.; Liversidge, G. G.; Cooper, E. R. Nanosizing: A formulation approach for poorly water soluble compounds. Eur. J. Pharm. Sci. 2003, 18, 113-120.
14. Muller, R. H.; Jacobs, C.; Kayser, O. Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future. Adv. Drug Delivery Rev. 2001, 47, 3-19.
15. Merisko-Liversidge, E.; McGurk, S. L.; Liversidge, G. G. Insulin nanoparticles: A novel formulation approach for poorly water soluble Zn-insulin. Pharm. Res. 2004, 21, 1545-1553.
16. Pecora, R. Dynamic light scattering measurement of nanometer particles in liquids. J. Nanopart. Res. 2000, 2, 123-131.
17. Liu, B. H.; Wu, T. S.; Su, M. C.; Chung, C. P.; Yu, F. Y. Evaluation of citrinin occurrence and cytotoxicity in Monascus fermentation products. J. Agric. Food Chem. 2005, 53, 170-175.
18. Lee, C. L.; Wang, J. J.; Pan, T. M. A synchronous analysis method for detection of citrinin and the lactone and the acid form of monacolin K in red mold rice. J. AOAC Int. 2006, 89, 669-677.
19. Hajjaj, H.; Blanc, P.; Groussac, E.; Uribelarrea, J.; Goma, G.; Loubiere, P. Kinetic analysis of red pigment and citrinin production by Monascus ruber as a function of organic acid accumulation. Enzyme Microb. Technol. 2000, 27, 619-625.
20. Lin, C. F.; Iizuka, H. Production of extracellular pigment by mutant of Monascus kaoliang sp. nov. Appl. Environ. Microbiol. 1982, 43, 671-676.
21. AOAC. Official Methods of Analysis, 14th ed.; Association of Official Analytical Chemists: Washington, DC, 1984.
22. Tseng, Y. Y.; Chen, M. T.; Lin, C. F. Growth, pigment production and protease activity of Monascus purpureus as affected by salt, sodium nitrite, polyphosphate and various sugars. J. Appl. Microbiol. 2000, 88, 31-37.
23. Lin, C. W; Chou, W. L. Strain screening of Monascus sp. on oriental type cheese manufacturing and its mycological profile. J. Chin. Anim. Sci. 1998, 27, 143-162.
24. Radtke, M. Pure drug nanoparticles for the formulation of poorly soluble drugs. J. New Drugs 2001, 3, 62-68.
25. Liversidge, G. G.; Cundy, K. C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 1995, 125, 91-97.
26. Liversidge, G. G.; Conzentino, P. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rates. Int. J. Pharm. 1995, 125, 309-313.
27. Merisko-Liversidge, E.; Sarpotdar, P.; Bruno, J.; Hajj, S.; Wei, L.; Peltier, N.; Rake, J.; Shaw, J. M.; Pugh, S.; Polin, L.; Jones, J.; Corbett, T.; Cooper, E.; Liversidge, G. G. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 1996, 13, 272-278.
28. Liversidge, G. G. Drug nanocrystals for improved drug delivery. Int. Symp. Control. Release Bioact. Mater. Workshop on particulate drug delivery systems, 1996; Vol. 23.
29. Gurr, M. I.; Asp, N. G. Dietary Fibre, 2nd ed.; ILSI Press: Washington, DC, 1994.
30. Lee, C. L.; Wang, J. J.; Pan, T. M. Increasing monacolin K production of Monascus spp. under low pH value condition. Proc. Gen. Meeting Am. Soc. Microbiol. 2005, 433.
31. Liu, X.; Chung, C. K. Germination activated Ganoderma lucidum spores and method for producing the same. U.S. Patent 6,468,542, 2002.
32. Chung, C. K.; Tong, S. K. Ganoderma lucidum spores for treatment of autoimmune diseases. U.S. Patent 6,893,641, 2005.
33. Monaghan, R. L.; Alberts, A. W.; Hoffman, C. H.; Albers-Schonberg, G. Hypocholesteremic fermentation products and process of preparation. U.S. Patent 4,231,938, 1980.
34. Farber, B. Y.; Graves, G. A. Ceramic Media with improved efficiency. PCI 2001, Apr, 30-41.